Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 6/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.37 |
| ▸ | ATXN2 | Q99700 | 3/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.35 |
| ▸ | LPL | P06858 | 2/20 | 0.35 |
| ▸ | LIPC | P11150 | 2/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | JAK1 | P23458 | 1/20 | 0.34 |
| ▸ | TYK2 | P29597 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30700147 | 0.86 | MGLL (0.46) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30700301 | 0.86 | MGLL (0.44) | MGLLFAAHENPP2ATXN2LIPG | |
| SCHEMBL27289695 | 0.86 | MGLL (0.46) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30700174 | 0.86 | MGLL (0.46) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30700009 | 0.86 | MGLL (0.46) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30700176 | 0.86 | MGLL (0.46) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL27289691 | 0.86 | MGLL (0.46) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30699982 | 0.85 | MGLL (0.44) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30700343 | 0.85 | MGLL (0.44) | MGLLFAAHENPP2ATXN2PIK3CA | |
| SCHEMBL30700543 | 0.85 | MGLL (0.44) | MGLLFAAHENPP2ATXN2PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543870-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2025-04-30 | — | — | EP | claimed |
| WO-2023247670-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-12-28 | — | — | WO | claimed |
| WO-2023247670-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-12-28 | — | — | WO | disclosed |